infant health

All of the active B12 group reporting showed reduction in severity of symptoms ranging from 31% to infant 70%, while the placebo controls reported either no change or a worsening health of symptoms. Wilcoxon-Rank of .002 for the end-points of sneezing, nasal congestion and runny nose; and p = .005 for IgE reductions. In 1992, the above mentioned data from 1988 on were presented by Dr. O''Connor to the FDA. The FDA panel acknowledged infant and health the safety of the treatment. The panel seemed to be in agreement that the statistics indicated a significant reduction in IgE and that a quantitative infant and health drop in symptoms was demonstrated. infant and health and infant In 1992, Belen Anibarro, MD, studied five children with asthma with metabisulfite intolerance confirmed by oral challenge health testing. The test was repeated after premedication with 1.5 mg of oral cyanocobalamin. In four infant of the five patients treated, bronchospasm did not develop in the second metabisulfite challenge.6

In 1990 study in San Diego, CA the 5 active subjects health with allergic rhinitis had a lowered total serum IgE from Day 0 to Day 90 while 4 placebo subjects, (2 with allergic rhinitis, 1 with asthma and 1 with both), infant had flat or increased IgE levels.4 In a randomized, double-blind, placebo controlled study of symptoms and serum IgE levels in San Diego, CA in mid-1991, subjects had allergic rhinitis and/or asthma. Serum was drawn at Day 0 and Day 30. Seven of the 10 active treated subjects had a reduction health in total serum IgE levels. infant In 10 placebo treated subjects, 5 had levels of total serum IgE that stayed the same (plus or minus 5%), 3 decreased and 2 increased.5 Statistical analysis of the open-label study as well as the double-blind randomized placebo controlled study have health shown a significant effect of vitamin B12 in lowering serum IgE concentrations.

©2003 www.homeopathic-nutrition-health.com. All rights reserved.